
Sagal Pannu/X
Jun 3, 2025, 09:33
Sagal Pannu: Tarlatamab and Emerging Bispecific T-cell Engagers Changing the Treatment Landscape of SCLC
Sagal Pannu, Associate Research Scholar at OU Health Stephenson Cancer Center, posted on X:
“Stellar talk by Rafeh Naqash on tarlatamab and emerging bispecific T-cell engagers changing the treatment landscape of SCLC, understanding the mechanism of action and toxicities as well as management strategies to optimise use!”
Read Further: 15 Posts Not to Miss from the 3rd Day of ASCO 2025.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 4, 2025, 17:02
Jun 4, 2025, 16:33
Jun 4, 2025, 16:33
Jun 4, 2025, 15:56